Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Merck to Buy Terns Pharmaceuticals; Arm to Sell Its Own Chips; Braze Shares Climb | Stock Movers
Posted
March 25, 2026
Views
73
March 25, 2026
73
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:01
6:24
4:01Now PlayingToday's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Merck & Co (MRK) to buy Terns Pharmaceuticals (TERN) for $53/share in cash for an approximate equity value of $6.7 billion.
- Shares of Arm Holdings (ARM), which made its name licensing technology to semiconductor makers, rose in premarket trading after it said it will sell its own chips for the first time, in a move forecast to generate about $15 billion annually within five years.
- Braze shares rise after the software company forecast revenue for the first quarter that was higher than the average analyst estimate.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Merck to Buy Terns Pharmaceuticals; Arm to Sell Its Own Chips; Braze Shares Climb
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
